GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Talkspace Inc (NAS:TALK) » Definitions » 5-Year RORE %

TALK (Talkspace) 5-Year RORE % : -35.62% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Talkspace 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Talkspace's 5-Year RORE % for the quarter that ended in Dec. 2024 was -35.62%.

The industry rank for Talkspace's 5-Year RORE % or its related term are showing as below:

TALK's 5-Year RORE % is ranked worse than
83.57% of 493 companies
in the Healthcare Providers & Services industry
Industry Median: 5.16 vs TALK: -35.62

Talkspace 5-Year RORE % Historical Data

The historical data trend for Talkspace's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talkspace 5-Year RORE % Chart

Talkspace Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
5-Year RORE %
Get a 7-Day Free Trial - - - - -35.62

Talkspace Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -35.62

Competitive Comparison of Talkspace's 5-Year RORE %

For the Health Information Services subindustry, Talkspace's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talkspace's 5-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Talkspace's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Talkspace's 5-Year RORE % falls into.



Talkspace 5-Year RORE % Calculation

Talkspace's 5-Year RORE % for the quarter that ended in Dec. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.007--1.083 )/( -3.06-0 )
=1.09/-3.06
=-35.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2024 and 5-year before.


Talkspace  (NAS:TALK) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Talkspace 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Talkspace's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Talkspace Business Description

Traded in Other Exchanges
N/A
Address
622 Third Avenue, New York, NY, USA, 10017
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
Executives
Gil Margolin officer: Chief Technology Officer C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Jon R Cohen director C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
John Charles Reilly officer: General Counsel and Secretary C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Steven Dziedzic officer: Chief Product Officer C/O TALKSPACE, INC., 2578 BROADWAY #607, NEW YORK NY 10025
Michael E Hansen director C/O TALKSPACE, INC., 2578 BROADWAY #607, NEW YORK NY 10025
Douglas L Braunstein director, officer: President, Chairman HUDSON EXECUTIVE CAPITAL LP, 570 LEXINGTON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jeffrey Crowe director 525 UNIVERSITY AVENUE, SUITE 800, PALO ALTO CA 94301
Hudson Executive Capital Lp 10 percent owner C/O CADWALADER, WICKERSHAM & TAFT, LLP, 200 LIBERTY STREET, NEW YORK NY 10281
Erin Boyd officer: Chief Growth Officer C/O TALKSPACE, INC., 2578 BROADWAY #607, NEW YORK NY 10025
Jennifer Fulk officer: Chief Financial Officer C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Oren Frank director, officer: CEO C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Roni Frank director, officer: Head of Clinical Services 28 LEROY STREET, TENAFLY NJ 07670
Samara H. Braunstein officer: Chief Marketing Officer 1030 FIFTH AVENUE, #5E, NEW YORK NY 10028
Madhu Pawar director C/O TALKSPACE NETWORK LLC, 2578 BROADWAY #607, NEW YORK NY 10025
Charles Berg director 48 MONROE TURNPIKE, TRUMBULL CT 06611